Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 1;19(10):1330-1337.
doi: 10.2215/CJN.0000000000000405. Epub 2024 Jan 22.

Effect of Remote and Virtual Technology on Home Dialysis

Susie Q Lew  1 , Sabrina Milan Manani  2 , Claudio Ronco  2 , Mitchell H Rosner  3 , James A Sloand  1
Affiliations
Review

Effect of Remote and Virtual Technology on Home Dialysis

Susie Q Lew et al. Clin J Am Soc Nephrol. .

Abstract

In the United States, regulatory changes dictate telehealth activities. Telehealth was available to patients on home dialysis as early as 2019, allowing patients to opt for telehealth with home as the originating site and without geographic restriction. In 2020, coronavirus disease 2019 was an unexpected accelerant for telehealth use in the United States. Within nephrology, remote patient monitoring has most often been applied to the care of patients on home dialysis modalities. The effect that remote and virtual technologies have on home dialysis patients, telehealth and health care disparities, and health care providers' workflow changes are discussed here. Moreover, the future use of remote and virtual technologies to include artificial intelligence and artificial neural network model to optimize and personalize treatments will be highlighted. Despite these advances in technology challenges continue to exist, leaving room for future innovation to improve patient health outcome and equity. Prospective studies are needed to further understand the effect of using virtual technologies and remote monitoring on home dialysis outcomes, cost, and patient engagement.

PubMed Disclaimer

Conflict of interest statement

S.Q. Lew reports spouse's employment with Mitre; consultancy for Triomed; and advisory or leadership role for George Washington University ACO Board of Director and Quality Insights Medical Review Board. S.Q. Lew reports other interests or relationships with ASN: COVID-19 home dialysis subcommittee, ASN: KHI member, ASN: KidneyX grant reviewer; ASN: Quality Committee member, NIA: grant reviewer, NIH's Kidney Precision Medical Project: Data Safety Monitoring Board member, and USFDA Gastroenterology and Urology Devices Panel of FDA's Medical Devices Advisory Committee. S.Q. Lew's spouse reports employment with Mitre; C. Ronco reports ownership interest in CR19 and New Progress Service srl; consultancy for Aferetica, Asahi, AstraZeneca, Baxter, B.Braun, Biomerieux, Bioporto, Cytosorbents, Estor, FMC, GE Healthcare, Jafron Biomedical, Medica, Medtronic, Ortho, and Toray; honoraria from Aferetica, Astute, Baxter, B.Braun, Cytosorbents, Estor, Fresenius, GE, Jafron, Medtronic, and Toray; advisory or leadership role as an Associate editor of Nephrology Dialysis and Transplantation, Editor-in-chief of Blood Purification and series editor of the book series Nephrology and Cardiorenal Medicine; and speakers bureau for Asahi, Baxter, Biomerieux, Cytosorbents, ESTOR, GE, and Jafron. M.H. Rosner reports honoraria from American Society of Nephrology, advisory or leadership role for American Society of Nephrology, advisory or leadership role as an Editor-at-Large for CJASN, and data safety monitoring board for Reata and Retrophin. J.A. Sloand is Chief Medical Officer of Simergent; reports consultancy for Cerovations, Sequana Medical, and Simergent; and reports ownership interest in AstraZeneca, Baxter Healthcare, and Simergent. The remaining author has nothing to disclose.

Figures

Figure 1
Figure 1
Improving home dialysis patients' outcome with technology. PD, peritoneal dialysis.
See this image and copyright information in PMC

References

    1. HealthIT.gov. What Is Telehealth? How Is Telehealth Different from Telemedicine?; 2019. Accessed April 28, 2023. https://www.healthit.gov/faq/what-telehealth-how-telehealth-different-te...
    1. World Health Organization. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth (Global Observatory for EHealth Series, Volume 2); 2010. Accessed March 19, 2023. http://apps.who.int/iris/bitstream/handle/10665/44497/9789241564144_eng....
    1. NEJM Catalyst. What Is Telehealth?; 2018. Accessed March 19, 2023. doi: 10.1056/CAT.18.0268 - DOI
    1. U.S. Food and Drug Administration. Digital Health; 2020. Accessed March 19, 2023. https://www.fda.gov/medical-devices/digital-health
    1. Baker J, Stanley A. Telemedicine technology: a review of services, equipment, and other aspects. Curr Allergy Asthma Rep. 2018;18(11):60. doi: 10.1007/s11882-018-0814-6 - DOI - PubMed

MeSH terms

LinkOut - more resources